GLIOMATCH 3rd consortium meeting takes place in Düsseldorf, Germany
From 25 to 27 March 2025, the GLIOMATCH consortium convened in Düsseldorf, Germany, for its third consortium meeting. The meeting was held in-person and hosted by the partner University of Düsseldorf (UDUS). Over 40 experts from across Europe gathered to assess progress of the past year and plan the next phase of the GLIOMATCH project.
International Day of Women and Girls in Science 2025
On the 10th anniversary of the International Day of Women and Girls in Science, GLIOMATCH celebrates the women driving our research and our commitment to gender balance in science and leadership.
World Cancer Day 2025
On World Cancer Day 2025, the GLIOMATCH project participated in the EU project showcase hosted by HaDEA, highlighting the role of EU-funded research in advancing cancer care. We have seized this opportunity to map the EU Cancer Mission project landscape.
GLIOMATCH Receives Ethical Approval for Retrospective Clinical Trials
The GLIOMATCH project has received ethical approval from the UZ/KU Leuven Ethics Committee to conduct retrospective clinical trials for adult and paediatric glioma patients. This follows earlier approvals for other project partners, setting data collection to begin in 2025,.
Spatial proteomics named 2024 Method of the Year by Nature Methods
Spatial proteomics, a technique which maps protein distributions within tissues with high resolution, is central to the GLIOMATCH project.
European Cancer Summit 2024
GLIOMATCH was featured at the European Cancer Summit 2024, held on 20–21 November in Brussels and online. We’re proud to support Europe’s fight against cancer.
Belgian Science Day 2024
GLIOMATCH project coordinator, Prof Frederik de Smet, held a lecture about how immunotherapy can be harnessed for brain cancer research.
July 2024 is Glioblastoma Awareness Month
Glioblastoma Awareness Day (GBM Day) on 17 July 2024 aimed to raise awareness and support for those affected by glioblastoma, an aggressive brain tumour. GLIOMATCH’s month-long campaign is summarised in this article, highlighting the critical need for further research.
GLIOMATCH project kick-off meeting takes place in Leuven, Belgium
The GLIOMATCH project kick-off meeting took place from 25-27 March 2024 and was hosted by KU Leuven, the project coordinator, at the Faculty Club in Leuven, Belgium. This marks the first in-person gathering of the project’s 14 partner institutions.
GLIOMATCH: Pioneering personalised therapies for malignant glioma, a devastating brain cancer
According to the World Health Organisation, cancer ranks as the world’s second-leading cause of death. Brain tumours have particularly high mortality rates. The GLIOMATCH project is set to rewrite this narrative.